Avid Bioservices Inc (CDMO)

[jakedogman1]

I want to say the sunrise trial cost over $100 mil. The R&D spend thru 2006 has been close to $300 mil. I would argue the money has not been well spent with some major strategic blunders committed. If sunrise was a success mgmt would have been heroes. But it didn't work out that way.

So the value of the IP is what someone will pay for it after determining the costs to further develop and the revenue potential if and when approved. And mgmt does not have the resources to develop. Mix that up with the plethora of other possibilities of all the various compounds being studied. And time is moving at warp speed in the lab and geologic time in the trials. New combos and MOA's are being discovered before trials can even enroll the first patient. Thus the 64 dollar question.